Biologically Refined Oncological Resectability for Hepatocellular Carcinoma

Puntos clave

• The research aims to enhance the prediction of early recurrence in hepatocellular carcinoma by refining oncological resectability using specific biomarkers.
• Utilized AFP and DCP biomarkers for refinement of oncological resectability assessment.
• Identified aggressive subsets within the R group.
• Evaluated the potential for improving early recurrence prediction.
• Refinement using AFP and DCP allows for identifying a biologically aggressive subset.
• May lead to improved early recurrence prediction.